MedPath

Brain Training Game Shows Promise for Drug-Free Nerve Pain Treatment in First Clinical Trial

3 months ago3 min read

Key Insights

  • Researchers from the University of New South Wales developed PainWaive, an interactive brain training system that teaches patients to alter their brainwaves through neurofeedback games for nerve pain management.

  • In the first clinical trial, three out of four participants with corneal neuropathic pain experienced significant pain reductions five weeks after completing 20 treatment sessions over four weeks.

  • The system combines an EEG headset that records brain activity with an app featuring neurofeedback games, offering a potential non-invasive, in-home alternative to opioid treatments.

A novel brain training system that teaches patients to control their own brainwaves has demonstrated promising results in treating chronic nerve pain, according to the first clinical trial of the technology published in The Journal of Pain in April. The study, led by psychologists from the University of New South Wales in Sydney, Australia, offers hope for drug-free pain management alternatives.

Revolutionary Neurofeedback Approach

The PainWaive system represents a breakthrough in non-invasive pain treatment, combining an electroencephalogram (EEG) headset that records brain activity with an interactive app featuring neurofeedback games. The technology allows patients to visualize their brain activity in real-time through engaging imagery, such as a jellyfish drifting through water that changes color as the user's mental state shifts.
"As your mind calms, the water turns turquoise," researchers describe the user experience. "The headset you're wearing has picked up a subtle shift in your brainwaves and the game responds by altering the imagery. Now, for the first time, you can see your brain activity change. And by seeing it, you can practice making it happen again."

Clinical Trial Results

The initial trial focused on four participants suffering from corneal neuropathic pain, a challenging condition that causes painful hypersensitivity of the eyes, face, or head. This condition rarely responds to current treatments, and doctors remain uncertain about its exact causes.
Participants underwent 20 PainWaive sessions over four weeks, learning to regulate abnormal brain activity that underlies nerve pain. The results proved encouraging: three out of four participants experienced significant reductions in pain five weeks after completing their final treatment session.

Addressing Unmet Medical Needs

The research team hypothesized that altering brainwaves generally associated with nerve pain could provide relief for conditions that resist conventional therapies. The PainWaive system was specifically designed as a potential in-home, non-invasive alternative to opioids for managing chronic nerve pain.
The technology's ability to train users to self-regulate their brain activity represents a significant departure from traditional pain management approaches, offering patients direct control over their treatment process through interactive neurofeedback games.

Future Implications

The promising initial results suggest that neurofeedback-based treatments could herald a new generation of drug-free pain management solutions. The system's design for home use could make it particularly valuable for patients with chronic conditions who require ongoing pain management but wish to avoid pharmaceutical interventions.
The research demonstrates the potential for technology-assisted brain training to address complex neurological conditions, particularly those involving abnormal brain activity patterns associated with chronic pain states.
Subscribe Icon

Stay Updated with Our Daily Newsletter

Get the latest pharmaceutical insights, research highlights, and industry updates delivered to your inbox every day.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.